CTOs on the Move


 
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nymox.com
  • Heights Plaza 777 Terrace Avenue
    Hasbrouck Heights, NJ USA 07604
  • Phone: 800.936.9669

Executives

Name Title Contact Details

Funding

Nymox raised $16.3M on 04/12/2018

Similar Companies

Aldie Foundation Inc

Aldie Foundation Inc is a Doylestown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Choice Michigan

Community Choice Michigan is a Okemos, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Monitored Caregiving Health

Advanced Monitored Caregiving Health is a leading provider of customized, scalable and cost-effective “real-time” patient management solutions that assist organizations serving at-risk populations or that conduct clinical trials. Its patient engagement, health monitoring and care coordination solutions have been proven in several studies published in peer-reviewed journals to improve patient outcomes and quality of care, and reduce overall healthcare costs. AMC Health is headquartered in New York City.

DDB Corbett

DDB Corbett is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Entelos

Entelos is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.